Allergic eye disease mechanisms.
作者信息
McGill J I, Holgate S T, Church M K, Anderson D F, Bacon A
机构信息
Southampton University Hospitals, Southampton General Hospital, USA.
出版信息
Br J Ophthalmol. 1998 Oct;82(10):1203-14. doi: 10.1136/bjo.82.10.1203.
Abstract
摘要
相似文献
1
Allergic eye disease mechanisms.过敏性眼病机制。
Br J Ophthalmol. 1998 Oct;82(10):1203-14. doi: 10.1136/bjo.82.10.1203.
2
T-cell characterization in chronic allergic eye disease.
Curr Allergy Asthma Rep. 2003 Jul;3(4):358-62. doi: 10.1007/s11882-003-0099-1.
3
Ocular mast cells. Characterization in normal and disease states.眼部肥大细胞。正常及疾病状态下的特征。
Clin Rev Allergy Immunol. 2001 Apr;20(2):243-68. doi: 10.1385/CRIAI:20:2:243.
4
Conjunctival mast cells in ocular allergic disease.眼部过敏性疾病中的结膜肥大细胞。
Allergy Asthma Proc. 2001 May-Jun;22(3):121-6. doi: 10.2500/108854101778148782.
5
Do local Th2-driven or local IgE-mediated diseases exist without systemic IgE-sensitization?
Allergy. 2002 May;57(5):373-4. doi: 10.1034/j.1398-9995.2002.00337.x.
6
Human ocular mast cells.人类眼部肥大细胞。
Curr Opin Allergy Clin Immunol. 2002 Oct;2(5):419-22. doi: 10.1097/00130832-200210000-00009.
7
IgE-mediated hypersensitivity reactions.IgE介导的超敏反应。
Otolaryngol Head Neck Surg. 1993 Sep;109(3 Pt 2):565-78.
8
Ocular allergy.
Clin Allergy. 1988 Jan;18(1):1-13. doi: 10.1111/j.1365-2222.1988.tb02837.x.
9
Immune mechanisms in allergic eye diseases: what is new?变应性眼病的免疫机制：有哪些新进展？
Curr Opin Allergy Clin Immunol. 2009 Oct;9(5):477-81. doi: 10.1097/ACI.0b013e3283303e2e.
10
Bibliography. Current world literature. Eye allergy.
Curr Opin Allergy Clin Immunol. 2008 Oct;8(5):495-7.
引用本文的文献
1
Effect of Exposure to Particulate Matter on the Ocular Surface in an Experimental Allergic Eye Disease Mouse Model.暴露于颗粒物对实验性变应性眼病小鼠模型眼表的影响。
Bioengineering (Basel). 2024 May 16;11(5):498. doi: 10.3390/bioengineering11050498.
2
Vernal Keratoconjunctivitis among Patients Presenting to the Outpatient Department of Ophthalmology of a Tertiary Care Centre: A Descriptive Cross-sectional Study.春季角结膜炎患者在眼科门诊就诊：一项描述性横断面研究。
JNMA J Nepal Med Assoc. 2023 Jan 1;61(257):14-17. doi: 10.31729/jnma.7933.
3
TFOS lifestyle: Impact of societal challenges on the ocular surface.TFOS 生活方式：社会挑战对眼表的影响。
Ocul Surf. 2023 Apr;28:165-199. doi: 10.1016/j.jtos.2023.04.006. Epub 2023 Apr 14.
4
Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases.用于治疗眼部炎症性疾病的富含生长因子血浆膜的优化
Bioengineering (Basel). 2022 Sep 27;9(10):508. doi: 10.3390/bioengineering9100508.
5
Vernal keratoconjunctivitis: culmination of management using immunosuppression, surgical and prosthetic therapy over quarter century.春季角结膜炎：25 年来免疫抑制、手术及义眼治疗综合管理的成果
BMJ Case Rep. 2016 Nov 23;2016:bcr2016217759. doi: 10.1136/bcr-2016-217759.
6
Hydrocortisone concentration influences time to clinically significant healing of acute inflammation of the ocular surface and adnexa - results from a double-blind randomized controlled trial.氢化可的松浓度影响眼表和附属器急性炎症临床显著愈合的时间 - 一项双盲随机对照试验的结果。
BMC Ophthalmol. 2014 May 10;14:64. doi: 10.1186/1471-2415-14-64.
7
Nasal-ocular reflexes and their role in the management of allergic rhinoconjunctivitis with intranasal steroids.鼻-眼反射及其在鼻内用类固醇治疗变应性鼻结膜炎中的作用。
World Allergy Organ J. 2011 Jan;4(1 Suppl):S1-5. doi: 10.1097/WOX.0b013e3181f32dcd.
8
Updates in the treatment of ocular allergies.眼部过敏治疗的新进展。
J Asthma Allergy. 2010 Nov 24;3:149-58. doi: 10.2147/JAA.S13705.
9
Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.过敏性结膜炎治疗方面的近期专利与新兴疗法
Recent Pat Inflamm Allergy Drug Discov. 2011 Jan;5(1):26-36. doi: 10.2174/187221311794474883.
10
本文引用的文献
1
ANTIBODIES TO GRASS IN VERNAL CONJUNCTIVITIS.春季结膜炎中的草抗体。
J Allergy. 1963 Nov-Dec;34:535-43. doi: 10.1016/0021-8707(63)90095-9.
2
Rapid onset of action of levocabastine eye-drops in histamine-induced conjunctivitis.左卡巴斯汀滴眼液在组胺诱导的结膜炎中起效迅速。
Clin Exp Allergy. 1993 Sep;23(9):791-4. doi: 10.1111/j.1365-2222.1993.tb00368.x.
3
Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leucocyte infiltration.季节性变应性结膜炎伴有肥大细胞数量增加，且无白细胞浸润。
Clin Exp Allergy. 1997 Sep;27(9):1060-6. doi: 10.1111/j.1365-2222.1997.tb01258.x.
4
A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis. Loteprednol Allergic Conjunctivitis Study Group.氯替泼诺酯在季节性变应性结膜炎预防性治疗中疗效和安全性的对照评估。氯替泼诺变应性结膜炎研究组。
Am J Ophthalmol. 1997 Jun;123(6):791-7. doi: 10.1016/s0002-9394(14)71128-6.
5
Double-blind, randomised, placebo-controlled study of two concentrations of azelastine eye drops in seasonal allergic conjunctivitis or rhinoconjunctivitis.两种浓度氮卓斯汀滴眼液治疗季节性变应性结膜炎或鼻结膜炎的双盲、随机、安慰剂对照研究
Curr Med Res Opin. 1997;14(1):21-8. doi: 10.1185/03007999709113339.
6
Adhesion molecules and relationship to leukocyte levels in allergic eye disease.黏附分子及其与变应性眼病中白细胞水平的关系。
Invest Ophthalmol Vis Sci. 1998 Feb;39(2):322-30.
7
Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells.局部眼部抗过敏药物对人结膜肥大细胞的比较作用。
Ann Allergy Asthma Immunol. 1997 Dec;79(6):541-5. doi: 10.1016/S1081-1206(10)63063-3.
8
Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.细胞因子在正常和过敏性结膜中肥大细胞上的免疫定位。
Clin Exp Allergy. 1997 Nov;27(11):1328-34.
9
The effect of azelastine on the infiltration of inflammatory cells into the bronchial mucosa and clinical changes in patients with bronchial asthma.
Int Arch Allergy Immunol. 1997 Nov;114(3):285-92. doi: 10.1159/000237681.
10
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.洛度沙胺滴眼液对过敏性结膜炎变应原激发后肥大细胞和嗜酸性粒细胞的疗效。
Ophthalmology. 1997 May;104(5):849-53. doi: 10.1016/s0161-6420(97)30223-1.
Zotero 插件